Trials, therapies, and evidence that changes care.
From the archiveYou are reading the October 7, 2026 edition. Read the latest
Europe PMC
Verdict: NotableBackground RIPK1, a protein regulating inflammatory signalling and cell death, is implicated in amyotrophic lateral sclerosis (ALS) pathophysiology.
Early risk stratification of COVID-19 patients at admission informs triage and resource allocation, particularly in low- and middle-income settings where intensive-care capacity is constrained.
Objective In prespecified analyses, the treatment effect for major adverse cardiovascular event (MACE) of tirzepatide compared with imputed placebo was estimated using SURPASS-Cardiovascular Outcomes Trial…
Purpose We aimed to investigate the prognostic and predictive value of tumor-infiltrating lymphocytes (TIL) for adjuvant immunotherapy in high-risk early triple-negative breast cancer (TNBC).
Undernutrition and infectious diseases pose a double threat to child survival, especially in areas with a high malnutrition burden and low vaccination coverage.
Background WHO grade 2 atypical meningioma is a primary brain tumour with a high risk of recurrence even after complete surgical resection.
Background The clinical effects of dual antiplatelet therapy de-escalation after acute myocardial infarction may differ by age.